OY LX Therapies
Helsinki
About OY LX Therapies
Lx Therapies, founded in 2008, is a drug discovery company focused on developing genemediated therapies for the prevention and treatment of diseases of lymphatic vasculature. The initial focus of the company is on breast cancer-related lymphoedema, a relatively common complication of breast cancer treatment for which there is currently no cure or effective treatment. Lx Therapies, based in Helsinki, has received a EUR 2 million investment from Inveni Capital, the Finnish-German life sciences venture fund and a founder of Lx Therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $2.6M
- Last round: Series Unknown (Jan 2009)
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/oy-lx-therapies-2745892 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.